70 related articles for article (PubMed ID: 11246934)
1. Use of orally administered anhydrous crystalline maltose for relief of dry mouth.
Fox PC; Cummins MJ; Cummins JM
J Altern Complement Med; 2001 Feb; 7(1):33-43. PubMed ID: 11246934
[TBL] [Abstract][Full Text] [Related]
2. A third study on the use of orally administered anhydrous crystalline maltose for relief of dry mouth in primary Sjögren's syndrome.
Fox PC; Cummins MJ; Cummins JM
J Altern Complement Med; 2002 Oct; 8(5):651-9. PubMed ID: 12470447
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
4. Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group.
Ship JA; Fox PC; Michalek JE; Cummins MJ; Richards AB
J Interferon Cytokine Res; 1999 Aug; 19(8):943-51. PubMed ID: 10476942
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
7. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
Alves MB; Motta AC; Messina WC; Migliari DA
Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
[TBL] [Abstract][Full Text] [Related]
8. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögren's Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study.
Papas AS; Sherrer YS; Charney M; Golden HE; Medsger TA; Walsh BT; Trivedi M; Goldlust B; Gallagher SC
J Clin Rheumatol; 2004 Aug; 10(4):169-77. PubMed ID: 17043506
[TBL] [Abstract][Full Text] [Related]
10. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
Cummins MJ; Papas A; Kammer GM; Fox PC
Arthritis Rheum; 2003 Aug; 49(4):585-93. PubMed ID: 12910567
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z
Chin Med J (Engl); 2014; 127(15):2721-6. PubMed ID: 25146603
[TBL] [Abstract][Full Text] [Related]
12. Patient satisfaction and impact of salivary flow rate on effectiveness of xerostomia products.
Purdie MJ; Carpenter MD; Noll JL; Stephens CL; Taylor YJ; Hammitt KM; Napenas JJ; Brennan MT
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):236-241. PubMed ID: 36266177
[TBL] [Abstract][Full Text] [Related]
13. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
Erlichman M
Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
[TBL] [Abstract][Full Text] [Related]
15. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of topical dry mouth products containing olive oil, betaine, and xylitol in reducing xerostomia for polypharmacy-induced dry mouth.
Ship JA; McCutcheon JA; Spivakovsky S; Kerr AR
J Oral Rehabil; 2007 Oct; 34(10):724-32. PubMed ID: 17824884
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
Jensen SB; Vissink A
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
[TBL] [Abstract][Full Text] [Related]
18. Management of dry mouth: assessment of oral symptoms after use of a polysaccharide-based oral rinse.
Epstein JB; Villines DC; Singh M; Papas A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):76-83. PubMed ID: 27876580
[TBL] [Abstract][Full Text] [Related]
19. Xerostomia: recognition and management.
Fox PC
Dent Assist; 2008; 77(5):18, 20, 44-8; quiz 50-1. PubMed ID: 18982854
[TBL] [Abstract][Full Text] [Related]
20. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem.
Schiødt M; Oxholm P; Jacobsen A
Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
